OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation
Marie Friedrich, Lorenz Gerbeth, Marco Gerling, et al.
Mucosal Immunology (2019) Vol. 12, Iss. 3, pp. 656-667
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Role of Histone Post-Translational Modifications in Inflammatory Diseases
Yingying Lin, Ting Qiu, Guifeng Wei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55

The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
Huimin You, Yue Tan, Dawei Yu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 48

Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease
Hassan Melhem, Berna Kaya, Cemil Korcan Ayata, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 450-450
Open Access | Times Cited: 69

Propionate Enhances Cell Speed and Persistence to Promote Intestinal Epithelial Turnover and Repair
Anthony J. Bilotta, Chunyan Ma, Wenjing Yang, et al.
Cellular and Molecular Gastroenterology and Hepatology (2020) Vol. 11, Iss. 4, pp. 1023-1044
Open Access | Times Cited: 60

Opioids Impair Intestinal Epithelial Repair in HIV-Infected Humanized Mice
Jingjing Meng, Santanu Banerjee, Li Zhang, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 58

Molecular mechanisms and therapeutic possibilities of short-chain fatty acids in posttraumatic stress disorder patients: a mini-review
Pavlo Petakh, Khrystyna Duve, Valentyn Oksenych, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6

The crucial role of SETDB1 in structural and functional transformation of epithelial cells during regeneration after intestinal ischemia reperfusion injury
Makoto Ikenoue, Narantsog Choijookhuu, Koichiro Yano, et al.
Histochemistry and Cell Biology (2024) Vol. 161, Iss. 4, pp. 325-336
Closed Access | Times Cited: 5

Inhibition of HDAC6 Attenuates Diabetes-Induced Retinal Redox Imbalance and Microangiopathy
Hossameldin Abouhish, Menaka C. Thounaojam, Ravirajsinh N. Jadeja, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 599-599
Open Access | Times Cited: 31

Histone deacetylases as targets in autoimmune and autoinflammatory diseases
Patricia Hamminger, Ramona Rica, Wilfried Ellmeier
Advances in immunology (2020), pp. 1-59
Closed Access | Times Cited: 30

Epigenetic‐modifying therapies: An emerging avenue for the treatment of inflammatory skin diseases
Julie Z. Yi, Jean S. McGee
Experimental Dermatology (2021) Vol. 30, Iss. 8, pp. 1167-1176
Closed Access | Times Cited: 26

ADORA3 activation promotes goblet cell differentiation via enhancing HMGCS2-mediated ketogenesis in ulcerative colitis
Xi Zeng, Yuxiao Hu, Simiao Qiao, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112729-112729
Closed Access | Times Cited: 3

HDAC inhibitors and IBD: Charting new approaches in disease management
Xueting Du, Weilai Yu, Fangyu Chen, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114193-114193
Closed Access

Histone deacetylase in inflammatory bowel disease: novel insights
Chunxiao Li, Shaobo Gu, Yihong Zhang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access

The Antiangiogenesis Role of Histone Deacetylase Inhibitors: Their Potential Application to Tumor Therapy and Tissue Repair
Bin Deng, Qing Luo, Alexander Halim, et al.
DNA and Cell Biology (2019) Vol. 39, Iss. 2, pp. 167-176
Closed Access | Times Cited: 29

Pioglitazone Attenuates Experimental Colitis-Associated Hyperalgesia through Improving the Intestinal Barrier Dysfunction
Yulin Huang, Chenchen Wang, Xinyu Tian, et al.
Inflammation (2020) Vol. 43, Iss. 2, pp. 568-578
Open Access | Times Cited: 27

Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC
Bing Liang, Yanhong Wang, Jiazhen Xu, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
Long He, Shuting Wen, Zhuotai Zhong, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 20

Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies
Lorenz Gerbeth, Rainer Glauben
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 18

Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives
Mohammed Ghiboub, Ahmed M I Elfiky, Menno P.J. de Winther, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 5, pp. 336-336
Open Access | Times Cited: 18

Regulation of homeostasis and regeneration in the adult intestinal epithelium by the TGF‐β superfamily
Mardi Fink, Jeffrey L. Wrana
Developmental Dynamics (2022) Vol. 252, Iss. 4, pp. 445-462
Open Access | Times Cited: 14

Regulation of chromatin organization during animal regeneration
Xiaohui Jia, Weifeng Lin, Wei Wang
Cell Regeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7

How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let’s crosstalk about it!
William D. Rees, Laura M. Sly, Theodore S. Steiner
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 309-321
Closed Access | Times Cited: 20

Epigenetic histone modulation contributes to improvements in inflammatory bowel disease via EBI3
Alexandra Wetzel, Bettina Scholtka, Christian Gerecke, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 23, pp. 5017-5030
Open Access | Times Cited: 19

The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases
Horia Minea, Ana-Maria Sîngeap, Manuela Minea, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8420-8420
Open Access | Times Cited: 2

Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 9, pp. 1540-1554
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top